Becton Dickinson and Co- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Becton Dickinson and Co 公司

碧迪医疗是一家全球医疗技术公司。该公司从事医疗机构、医生、生命科学研究人员、临床实验室等使用的各种医疗用品、设备、实验室设备和诊断产品的开发、制造和销售。其 BD 医疗部门生产一系列医疗技术和设备，用于帮助改善各种环境中的医疗服务。BD 医疗部门由多个业务部门组成，包括药物输送解决方案、药物管理解决方案、高级监控和制药系统。其 BD 生命科学部门提供用于收集和运输诊断样本的产品，以及用于检测各种传染病、医疗相关感染和癌症的仪器和试剂系统。其 BD 介入部门提供血管、泌尿科、肿瘤科和外科专业产品。

公司简介

公司代码BDX

公司名称Becton Dickinson and Co

上市日期Sep 25, 1963

成立日期1906

CEOMr. Thomas E. Polen

员工数量74000

证券类型Ordinary Share

年结日Sep 25

公司地址One Becton Drive

城市FRANKLIN LAKES

上市交易所NYSE Consolidated

国家United States of America

邮编07417-1880

电话12018476800

网址https://www.bd.com/

公司代码BDX

上市日期Sep 25, 1963

成立日期1906

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Richard (Rick) Byrd

Executive Vice President, President - Interventional Segment

754.64K

-0.32%

Mr. Timothy M. (Tim) Ring

Independent Director

59.87K

+1.58%

Ms. Shana Carol Neal

Chief People Officer, Executive Vice President

47.02K

-3.86%

Ms. Catherine M. (Cathy) Burzik

Independent Director

14.81K

+6.70%

Mr. Roland Goette

Executive Vice President, President - EMEA

14.21K

-8.25%

Mr. Antoine C. Ezell

Executive Vice President, President, North America, Chief Marketing Officer

11.97K

+28.43%

Mr. Michael Feld

Executive Vice President, President - Life Sciences

9.19K

+38.45%

Mr. Robert Andrew (Andy) Eckert

Independent Director

9.14K

+11.33%

Ms. Michelle Quinn

Executive Vice President, General Counsel

6.93K

+39.80%

Dr. Carrie L. Byington, M.D.

Independent Director

5.25K

+21.54%

名称

名称/职务

职务

持股

持股变动

Mr. Richard (Rick) Byrd

Executive Vice President, President - Interventional Segment

754.64K

-0.32%

Mr. Timothy M. (Tim) Ring

Independent Director

59.87K

+1.58%

Ms. Shana Carol Neal

Chief People Officer, Executive Vice President

47.02K

-3.86%

Ms. Catherine M. (Cathy) Burzik

Independent Director

14.81K

+6.70%

Mr. Roland Goette

Executive Vice President, President - EMEA

14.21K

-8.25%

Mr. Antoine C. Ezell

Executive Vice President, President, North America, Chief Marketing Officer

11.97K

+28.43%

收入明细

单位: USD更新时间: 4月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Medication Delivery Solutions

1.12B

21.75%

Medication Management Solutions

801.00M

15.50%

Integrated Diagnostic Solutions

474.00M

9.17%

Peripheral Intervention

473.00M

9.15%

Specimen Management

462.00M

8.94%

Other

1.83B

35.49%

地区USD

名称

营收

占比

United States

3.08B

59.58%

International

2.09B

40.42%

业务

地区

业务USD

名称

营收

占比

Medication Delivery Solutions

1.12B

21.75%

Medication Management Solutions

801.00M

15.50%

Integrated Diagnostic Solutions

474.00M

9.17%

Peripheral Intervention

473.00M

9.15%

Specimen Management

462.00M

8.94%

Other

1.83B

35.49%

股东统计

更新时间: 4月26日周六

持股股东

股东类型

持股股东

股东统计

占比

The Vanguard Group, Inc.

9.27%

BlackRock Institutional Trust Company, N.A.

5.16%

State Street Global Advisors (US)

4.91%

T. Rowe Price Investment Management, Inc.

4.22%

T. Rowe Price Associates, Inc.

4.15%

Other

72.29%

持股股东

股东统计

占比

The Vanguard Group, Inc.

9.27%

BlackRock Institutional Trust Company, N.A.

5.16%

State Street Global Advisors (US)

4.91%

T. Rowe Price Investment Management, Inc.

4.22%

T. Rowe Price Associates, Inc.

4.15%

Other

72.29%

股东类型

股东统计

占比

Investment Advisor

41.45%

Investment Advisor/Hedge Fund

40.99%

Pension Fund

2.83%

Hedge Fund

2.51%

Research Firm

2.37%

Bank and Trust

1.64%

Sovereign Wealth Fund

1.23%

Individual Investor

0.57%

Insurance Company

0.28%

Other

6.12%

机构持股

更新时间: 1月19日周日

报告期

机构数

持股数

持股占比

持股变动

2025Q1

2842

271.04M

94.39%

-4.33M

2024Q4

2874

271.53M

94.56%

-4.62M

2024Q3

2787

266.29M

92.14%

-3.20M

2024Q2

2782

261.01M

90.31%

-2.68M

2024Q1

2797

255.99M

88.58%

-10.13M

2023Q4

2783

259.38M

89.78%

-7.79M

2023Q3

2768

264.64M

91.23%

-591.87K

2023Q2

2787

263.29M

90.78%

-570.64K

2023Q1

2795

257.22M

90.56%

-8.75M

2022Q4

2831

255.72M

90.07%

-14.76M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

26.61M

9.27%

+188.34K

+0.71%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

14.81M

5.16%

+196.28K

+1.34%

Dec 31, 2024

State Street Global Advisors (US)

14.09M

4.91%

+134.36K

+0.96%

Dec 31, 2024

T. Rowe Price Investment Management, Inc.

12.13M

4.22%

+3.22M

+36.14%

Dec 31, 2024

T. Rowe Price Associates, Inc.

11.93M

4.15%

-1.16M

-8.84%

Dec 31, 2024

Geode Capital Management, L.L.C.

6.35M

2.21%

+66.02K

+1.05%

Dec 31, 2024

Generation Investment Management LLP

5.82M

2.03%

-139.25K

-2.34%

Dec 31, 2024

Morgan Stanley Investment Management Ltd. (UK)

5.70M

1.98%

-310.28K

-5.16%

Dec 31, 2024

MFS Investment Management

5.45M

1.9%

+708.73K

+14.93%

Dec 31, 2024

First Eagle Investment Management, L.L.C.

4.43M

1.54%

+1.06M

+31.36%

Dec 31, 2024

持股ETF

更新时间: 4月6日周日

机构名称

占比

iShares U.S. Medical Devices ETF

4.18%

Natixis Vaughan Nelson Select ETF

4.12%

ClearBridge Dividend Strategy ESG ETF

3.3%

T Rowe Price Capital Appreciation Equity ETF

2.93%

First Eagle Global Equity ETF

2.82%

American Century Focused Large Cap Value ETF

2.61%

Touchstone US Large Cap Focused ETF

1.86%

ProShares MSCI Transformational Changes ETF

1.84%

T Rowe Price Equity Income ETF

1.76%

Running Oak Efficient Growth ETF

1.73%

iShares U.S. Medical Devices ETF

占比4.18%

Natixis Vaughan Nelson Select ETF

占比4.12%

ClearBridge Dividend Strategy ESG ETF

占比3.3%

T Rowe Price Capital Appreciation Equity ETF

占比2.93%

First Eagle Global Equity ETF

占比2.82%

American Century Focused Large Cap Value ETF

占比2.61%

Touchstone US Large Cap Focused ETF

占比1.86%

ProShares MSCI Transformational Changes ETF

占比1.84%

T Rowe Price Equity Income ETF

占比1.76%

Running Oak Efficient Growth ETF

占比1.73%

分红派息

近5年累计派现 5.34B 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

Jan 28, 2025

BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025

Mar 10, 2025

Mar 31, 2025

Mar 10, 2025

Nov 07, 2024

BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024

Dec 09, 2024

Dec 31, 2024

Dec 09, 2024

Jul 23, 2024

BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024

Sep 09, 2024

Sep 30, 2024

Sep 09, 2024

Apr 30, 2024

BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024

Jun 10, 2024

Jun 28, 2024

Jun 10, 2024

Jan 23, 2024

BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024

Mar 08, 2024

Mar 29, 2024

Mar 07, 2024

Nov 09, 2023

BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023

Dec 08, 2023

Dec 29, 2023

Dec 07, 2023

Jul 25, 2023

BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023

Sep 08, 2023

Sep 29, 2023

Sep 07, 2023

Apr 25, 2023

BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023

Jun 09, 2023

Jun 30, 2023

Jun 08, 2023

Jan 24, 2023

BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023

Mar 10, 2023

Mar 31, 2023

Mar 09, 2023

Nov 10, 2022

BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022

Dec 09, 2022

Dec 30, 2022

Dec 08, 2022

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Becton Dickinson and Co

174.215USD

Becton Dickinson and Co

174.215

概览

公司